Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Qiao, Guaiping"'
Autor:
Liang, Chengyuan, Qiao, Guaiping, Liu, Yuzhi, Tian, Lei, Hui, Nan, Li, Juan, Ma, Yuling, Li, Han, Zhao, Qianqian, Cao, Wenqiang, Liu, Hong, Ren, Xiaodong
Publikováno v:
In European Journal of Medicinal Chemistry 5 August 2021 220
Autor:
Liang, Chengyuan, Hui, Nan, Liu, Yuzhi, Qiao, Guaiping, Li, Juan, Tian, Lei, Ju, Xingke, Jia, Minyi, Liu, Hong, Cao, Wenqiang, Yu, Pengcheng, Li, Han, Ren, Xiaodong
Publikováno v:
In Phytomedicine Plus May 2021 1(2)
Autor:
Liang, Chengyuan, Tian, Lei, Liu, Yuzhi, Hui, Nan, Qiao, Guaiping, Li, Han, Shi, Zhenfeng, Tang, Yonghong, Zhang, Dezhu, Xie, Xiaolin, Zhao, Xu
Publikováno v:
In European Journal of Medicinal Chemistry 1 September 2020 201
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wenqiang Cao, Li Han, Zhao Qianqian, Lei Tian, Xiaodong Ren, Yuling Ma, Hui Nan, Liu Yuzhi, Qiao Guaiping, Li Juan, Liang Chengyuan, Hong Liu
Publikováno v:
European journal of medicinal chemistry. 220
All-trans-retinoic acid (ATRA) is effective for preventing cancer and treating skin diseases and acute promyelocytic leukaemia (APL). These pharmacological effects of ATRA are mainly mediated by retinoid X receptors (RXRs) and retinoic acid receptors
Autor:
Hui Nan, Xiaodong Ren, Pengcheng Yu, Hong Liu, Qiao Guaiping, Wenqiang Cao, Liu Yuzhi, Ju Xingke, Li Han, Jia Minyi, Lei Tian, Li Juan, Liang Chengyuan
Publikováno v:
Phytomedicine Plus
Phytomedicine Plus, Vol 1, Iss 2, Pp 100027-(2021)
Phytomedicine Plus, Vol 1, Iss 2, Pp 100027-(2021)
Highlights • The present review summarizes the plausible molecular mechanism of specific LH capsules in the control of SARS-COV-2 infection and the inhibition of cytokine storms caused by IL-6. • Preclinical and clinical trials of LH capsules in
Autor:
Xie Xiaolin, Li Han, Lei Tian, Tang Yonghong, Zhang Dezhu, Zhenfeng Shi, Qiao Guaiping, Xu Zhao, Hui Nan, Liu Yuzhi, Liang Chengyuan
Publikováno v:
European Journal of Medicinal Chemistry
Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor that can be used to treat a variety of RNA virus infections, is expected to be an effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecti